The QualityStocks Daily Monday, May 14th, 2018

Today's Top 3 Investment Newsletters

QualityStocks (CSRH) +78.95%

CannabisNewsWire (PRVCF) +39.51%

InvestorPlace (BONTQ) +30.91%

The QualityStocks Daily Stock List

RespireRx Pharmaceuticals, Inc. (RSPI)

Marketwired, MarketWatch, InvestorsHub, and Barchart reported on RespireRx Pharmaceuticals, Inc. (RSPI), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

RespireRx Pharmaceuticals, Inc. is a leader in the development of medicines for respiratory disorders. These disorders include sleep apneas and drug-induced respiratory depression. The Company formerly went by the name Cortex Pharmaceuticals, Inc. It changed its corporate name to RespireRx Pharmaceuticals, Inc. in December of 2015. RespireRx Pharmaceuticals is based in Glen Rock, New Jersey.

The Company has filed greater than 400 patents in the U.S. and offshore that claim composition of matter, use, formulation, dosage, and mechanism of action. Use claims include treating sleep apnea and preventing or rescuing drug-induced respiratory depression, and also for improving memory and cognition, treating schizophrenia and other central nervous system indications.

RespireRx’s pharmaceutical candidates in development are derived from two platforms. One platform is the class of compounds namedd cannabinoids. This includes, in particular, Dronabinol.

Dronabinol (D9-THC, D9-tetrahydrocannabinol) is an oral capsule drug product. It is undergoing testing for clinical efficacy in patients with obstructive sleep apnea (OSA). Under a license agreement with the University of Illinois, the Company has rights to patents claiming the use of cannabinoids for the treatment of sleep-related breathing disorders.

Dronabinol (D9-THC) is a generic, orally active cannabinoid. It has been shown to act at CB1 & CB2 receptors on neurons to stabilize respiratory patterns and augment upper airway muscles. Two Phase 2 clinical trials have been completed. Both have demonstrated considerable reductions in sleep apnea produced by dronabinol.

The other platform of medicines undergoing development by RespireRx Pharmaceuticals is a class of proprietary compounds named ampakines. These act to enhance the actions of the excitatory neurotransmitter glutamate at AMPA glutamate receptor sites in the brain. Several ampakines, in oral and injectable form, are undergoing development by the Company for the treatment of a variety of breathing disorders.

At the end of November 2017, RespireRx Pharmaceuticals announced that the results of the PACE (Pharmacotherapy of Apnea by Cannabimimetic Enhancement) clinical trial were published by the principal investigators, Dr. Pyllis Zee and Dr. David Carley at Northwestern University and at the University of Illinois at Chicago, respectively.  The PACE paper is published in the journal SLEEP, which is the official publication of the Sleep Research Society. Additionally, it is the foremost peer-reviewed journal in sleep and circadian science. Once per night treatment with Dronabinol provides statistically significant improvement in clinical measures of obstructive sleep apnea.

Last month, RespireRx Pharmaceuticals announced that a paper detailing the neurobiologic safety of the ampakine CX717 was accepted for publication by Toxicological Sciences, the Journal of the American Society of Toxicology. The paper, co-authored by RespireRx scientists in association with expert pathologists from around the nation who contributed to a wide-ranging neuropathology research program, presents clear scientific evidence that vacuoles discovered upon histological evaluation of brain tissue samples from animals treated with high doses of CX717, and which halted RespireRx’s promising CX717 clinical development effort, were actually an artifact of tissue processing rather than a toxic drug effect.

RespireRx Pharmaceuticals, Inc. (RSPI), closed Monday's trading session at $1.25, up 22.55%, on 375 volume with 2 trades. The average volume for the last 60 days is 1,674 and the stock's 52-week low/high is $0.80/$2.90.



OTC Markets, MarketWatch, InvestorsHub, Barchart, and Iconstockalerts reported on DOCASA, Inc. (DCSA), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

DOCASA, Inc. centers on investing in the fast-growing specialty coffee market, primarily in the United Kingdom (UK). The Company, by way of its subsidiary, Department of Coffee and Social Affairs Ltd. (London, England) has established and is building an award-winning, market leading UK specialty coffee shop and online retail business. OTCQB-listed, DOCASA is based in Schaumburg, Illinois.

The Company’s stores sell proprietary coffee and related products, as well as complementary food and snacks. Department of Coffee and Social Affairs served its first coffee in December of 2010 at Leather Lane, London. During the period December 2016 through February 2017, DOCASA opened four new shops in Kingston, Whitechapel, and Bank Street in London, and also one shop in Bristol.

DOCASA, through Department of Coffee and Social Affairs Limited, announced in August 2017 the launch in the United States of its award-winning specialty coffee shops, securing its first site at 800 Diversy in Chicago, Illinois.

Moreover, DOCASA is pursuing franchising and/or licensing of its branded shops and premium product offerings outside of the UK. This is in nations where the premium coffee market is fast developing.

DOCASA, via Department of Coffee and Social Affairs Limited, previously announced the securing of its first coffee shop site in Manchester, UK. This site is on the ground floor of Faulkner House, which is a 25,000-sq. ft. building of serviced offices, in Manchester's Piccadilly Gardens area. This site is the Department of Coffee and Social Affairs' flagship store and barista training hub in the northern part of England.

Overall, Department of Coffee and Social Affairs Limited’s locations include Leather Lane, Spitalfields Market, Norton Folgate, Whitechapel, Carnaby Street, Piccadilly, Warwick Street, Bank Street, and Canary Wharf in London. Locations also include Bristol, Kingston Upon Thames, Manchester, Macfarlanes (in the Law Offices of Macfarlanes on Cursitor Street in Chancery Lane), Wardour Street, and Chicago, Illinois.

DOCASA, Inc. (DCSA), closed Monday's trading session at $0.84, even for the day. The average volume for the last 60 days is 623 and the stock's 52-week low/high is $0.55/$2.00.


Aphria, Inc. (APHQF)

CFN Media Group and Cannabis Financial Network News reported previously on Aphria, Inc. (APHQF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Aphria, Inc. is one of Canada’s lowest cost producers that produces, supplies, and sells medical cannabis. The Company’s medical cannabis products are 100 percent greenhouse grown. Aphria works to provide pharmaceutical-grade medical cannabis and first-class patient care. Its commitment is to do this while balancing patient economics and returns to shareholders. Listed on the OTC Markets, Aphria is based in Leamington, Ontario.

The Company’s dedication is to ensuring patients receive consistent, safe, and effective medical cannabis products. Its cannabis oil products are produced utilizing C02 extraction methods. These methods preserve purity and ensure safety.

Aphria’s equivalency factor of cannabis oil to dried cannabis is 6:1. Therefore, every 6 mL of cannabis oil is equivalent to 1 gram of dried cannabis.

The Company is in the middle of a multi-phase expansion program. Upon completion of Part II, Aphria expects that yearly production capacity will reach 5,500 kilograms of dried cannabis and 9,000 liters of cannabis oil.

Aphria is a Health Canada Licensed Producer of medical cannabis products. The only legal access to medical cannabis in Canada is via Health Canada Licensed Producers. Nonetheless, some Canadians still have personal production licenses. This grants them authorization to produce medical cannabis for personal use.

In August 2017, Aphria announced that it invested $11.5 million in HydRx Farms, Ltd. (o/a Scientus Pharma). Scientus Pharma is a vertically-integrated biopharmaceutical company. It centers on the development of drugs that target the endocannabinoid receptors throughout the body for the treatment of diseases of the brain, organs, connective tissues, and more. Scientus Pharma is one of a limited number of Licensed Dealers in Canada authorized to handle and conduct cannabinoid product.

In April, Aphria announced that its first shipment of medical cannabis to its Australian-based partner Althea Company Pty Ltd. was received by Althea. The shipment is part of an earlier announced agreement between Aphria and Althea.

With this agreement Aphria will provide Althea with packaged co-branded cannabis oil and dried flower products for the Australian medical cannabis market. Before shipment, the Australian Governments' Office of Drug Control issued an import certificate and Health Canada issued an export certificate.

Aphria will rename its recently-acquired subsidiary Nuuvera as Aphria International, remaining as a wholly-owned subsidiary of Aphria. Aphria International will concentrate its activities on established regulated cannabis markets globally. This includes where Aphria International already has major interests.

At present, these markets encompass Europe, Africa and the Middle East, with assets and agreements in Germany, Italy, Spain, Portugal, Malta, Lesotho, and others. In addition, Aphria's existing assets and interests in Australia will be managed under Aphria International.

Aphria, Inc. (APHQF), closed Monday's trading session at $9.4554, up 5.66%, on 1,001,590 volume with 3,204 trades. The average volume for the last 60 days is 554,791 and the stock's 52-week low/high is $3.3953/$19.869.


Oroplata Resources, Inc. (ORRP)

OTC Markets, InvestorsHub,, CapitalCube, Stockhouse, Investcom, Stockopedia, Marketwired, SmallCap Network, and Stock of the Week reported on Oroplata Resources, Inc. (ORRP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Oroplata Resources, Inc., via its subsidiaries, engages in the exploration and development of lithium and other minerals. LithiumOre Corp is a wholly-owned subsidiary of Oroplata Resources. Oroplata engages in the development of lithium brine deposits in Nevada. Established in 2011, Oroplata Resources has its corporate office in Incline Village, Nevada. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Oroplata Resources’ LithiumOre subsidiary is a lithium resource exploration and development company. LithiumOre’s chief emphasis is the establishment of a low cost production base to supply the fast growing lithium-ion battery industry for mobile devices and laptops, and the escalating EV (electronic vehicle) industry.

At present, Oroplata Resources’ LithiumOre subsidiary has 5,200 acres in the region called the Western Nevada Basin in Railroad Valley in Nye County, Nevada (WNB Claim). Its claims have undergone evaluation by experts and the Bureau of Land Management (BLM) and determined that 260 claims of the WNB Claim were appropriate for LithiumOre’s planned exploration that the Company expects to commence in this first half of 2018.

In April, LithiumOre announced that it executed a strategic partnership with 3PL Operating, Inc. for the exploration of the Company's Western Nevada Basin lithium brine project in the Railroad Valley, Nevada. 3PL has considerable experience in drilling, development and production of oil and gas that is alike to lithium development since the metal is contained in liquid brines and produced from shallow wells. 3PL will drill on the Railroad Valley to obtain brine samples and evaluate lithium concentrations at the Western Nevada Basin project.

Additionally, in April, LithiumOre announced that it identified a number of zones indicative of a lithium brine aquifer at its Western Nevada Basin project in Railroad Valley.

Mr. Doug Cole, LithiumOre Chairman and Chief Executive Officer, said, "We believe this is the start of something potentially very big for the U.S. lithium sector and are excited about the results of the early studies that show several zones interpreted as potential brine. This reinforces the potential for our project to host lithium brines as suggested by a large geochemical shallow soils lithium anomaly in lake sediments that was previously reported in the area.”

Last week, LithiumOre provided an update for its Western Nevada Basin project. It is finalizing a drill contract. It expects to start drilling before the end of next month. The initial drilling will comprise three holes to test priority drill targets earlier identified during surveys.

This drilling program is scheduled to drill three holes utilizing a sonic drill rig to a depth of 3,300 feet each, collecting brine samples at varying intervals. The Company stated that this is a vital next step in a process that will enable its project to be better evaluated in the second half of this year.

Oroplata Resources, Inc. (ORRP), closed Monday's trading session at $0.27, down 15.62%, on 1,395,532 volume with 332 trades. The average volume for the last 60 days is 242,477 and the stock's 52-week low/high is $0.0575/$0.42.


Argentina Lithium & Energy Corp. (PNXLF)

Barchart, MarketWatch, Marketwired, and OTC Markets reported on Argentina Lithium & Energy Corp. (PNXLF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Argentina Lithium & Energy Corp. centers on the acquisition and exploration of natural resource properties in Argentina. The Company concentrates on acquiring high quality lithium projects in Argentina and advancing them towards production to meet the rising international demand from the battery sector. A natural resource enterprise, Argentina Lithium & Energy is headquartered in Vancouver, British Columbia. The Company has its Argentina Exploration Office in Mendoza, Argentina.

Argentina comprises a substantial portion of the Lithium Triangle. This is home to over half of the globe’s resources of lithium.

Argentina Lithium & Energy is a member of the Grosso Group. This is a resource management team, which pioneered the mineral exploration industry in Argentina. It has operated in the country since 1993. The Grosso Group leverages its wide-ranging network of local, regional, and worldwide industry contacts to support the exploration team in its search for quality resource opportunities.

Argentina Lithium & Energy has the option to earn a 100 percent interest in the Arizaro Lithium Brine Project. This includes 20,500 hectares in the central core of the Arizaro Salar, which is the largest in Argentina and the third largest in the Lithium Triangle. The geological environment at Arizaro includes volcanic rock outcrops and structural conditions similar to other salars in the Puna region where lithium and potash are found.

The central area of the Arizaro Salar is interpreted to have the geologic conditions to be the most prospective for quality brine resources. Additionally, the Arizaro Salar also benefits from a strategic location for infrastructure. This includes a railway that connects to the deep water port of Antofagasta, nearby advanced mining projects expected to bring major development of access routes and power, and also the availability of water for development.

Argentina Lithium & Energy reported in September 2017 that it initiated its first drilling and subsurface brine sampling program at the 20,500 hectare Arizaro Lithium Project on the Arizaro Salar in Salta Province.

This past November, Argentina Lithium & Energy announced that it acquired a 100 percent interest in, or has under application, mineral rights totaling 23,700 hectares encompassing the entire Incahuasi Salar and basin in Catamarca Province, Argentina.  This salar is within the “Lithium Triangle” of Argentina and Chile. It has characteristics prospective for lithium-rich brines. Initial sampling of near-surface brines returned up to 409mg/L lithium. Geophysical surveying indicates the potential for lithium-rich brines at depth.

Furthermore, in November, Argentina Lithium & Energy announced that the first two drill holes at the Arizaro project encountered lithium-bearing brines below surface in the central area of the salar with values as high as 257 mg/l lithium. A significant brine aquifer has not yet been reached. However, modest volumes of significantly anomalous lithium-bearing brines were retrieved beginning at depths of between 15 and 356 meters.

Recently, Argentina Lithium & Energy expanded the property holdings at the Arizaro project by an additional 7,030 ha. Geophysical and seismic surveying is the next step before a Phase II drill program to test for deep brines.

Argentina Lithium & Energy Corp. (PNXLF), closed Monday's trading session at $0.16, up 5.75%, on 26,190 volume with 11 trades. The average volume for the last 60 days is 10,195 and the stock's 52-week low/high is $0.0744/$0.479.


Vegalab, Inc. (VEGL)

OTC Markets, Simply Wall St, YCharts, Investors Hangout, Stockwatch, Capital Cube, Barchart, MarketWatch, InvestorsHub, TradingView, BusinessInsider, PennyStockHub, and InvestingNewsAlerts reported on Vegalab, Inc. (VEGL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Vegalab, Inc. is the exclusive distributor in North and South America of a line of all-natural, biologically derived pesticides, fertilizers, and specialty agricultural products. The Company’s products support a healthy soil biome. Additionally, they are cost competitive with synthetic chemicals that do just the opposite. The Company formerly went by the name HPC Acquisitions, Inc. It changed its corporate name to Vegalab, Inc. in November 2017. OTCQB-listed, Vegalab is based in North Palm Beach, Florida.

The Company’s products include Biocontrol Agents, Insecticides, Fungicides, Soil Inoculants, and Fertilizers. All of its oil-based products go through a process of micronization. This gives these oils the ability to cover a larger surface area and enabling deeper penetration into the crevices of plants, insects, and pathogens. The minute pores and filaments in the plant absorb Vegalab’s products faster in comparison to conventional oils.

Vegalab’s pesticides are highly effective against targeted organisms, non-toxic to beneficial organisms, and safe for the environment. Every Vegalab product strives to enhance productivity and decrease waste. The Company’s formulas and processes are the result of years of biological research and development (R&D), producing eco-safe, all-natural products.

Vegalab US purchased substantially all of the assets related to a produce packaging business in Tulare County, California. The acquisition closed on October 18, 2017.

The acquisition consisted of the purchase of approximately 11 acres of real property and 30,000 sq. ft. of buildings from M & G Farms, Inc. (a California corporation) and all of the equipment, inventory, customers, suppliers, contract rights, and intangible property from M&G Packing, Inc., the California Corporation that operated the Business.

Earlier in 2018, Vegalab announced the successful trials of its Pollen Boost product and initial first orders of Pollen Boost, which were for delivery in early February from Stanislaus Farm Supply, Buttonwillow Warehouse Company, and Mid Valley Agricultural Services, Inc.  The successful trials and first orders for Pollen Boost are a culmination of Vegalab’s focus on market leading, Earth friendly products that give farmers a substantial Return on Investment (ROI).

This past February, Vegalab provided a business update on M&G Packing that was purchased on October 18, 2017. The facility comprises roughly 11 acres of real property and 30,000 sq. ft. of buildings.

M&G Packing had about $8.6 million in fruit sales during the fiscal year (FY) ended September 30, 2017. Net income from operations for the period was $83,128. After the acquisition of M&G, the Company has received orders and shipped product at a level it believes to be consistent with M&G operations in its FY 2017.

In March, Vegalab announced that it completed its acquisition of The Agronomy Group, LLC effective as of February 1, 2018. The Agronomy Group (TAG) is located in Tulare County, California. It is a producer and distributor of environmentally friendly agrochemicals and also distributes other products. TAG had been Vegalab’s leading U.S. sales organization. Consequently, this acquisition significantly expands Vegalab’s internal marketing capability.

Vegalab, Inc. (VEGL), closed Monday's trading session at $3.00, even for the day, on 1,029 volume with 2 trades. The average volume for the last 60 days is 2,380 and the stock's 52-week low/high is $0.65/$5.24.


Hartford Retirement Network Corp. (HFRN)

Jet Life Penny Stocks, High Rising Stocks, StockPulse, Energy and Capital, Information Vine, Morningstar, InvestorsHub, Stockopedia, MarketWatch, Simply Wall St, Stockhouse, OTC Markets, InvestorsHangout, Barchart, GuruFocus, Infront Analytics, WalletInvestor, Penny Stock Hub, YCharts, TradingView, and Wallmine reported on Hartford Retirement Network Corp. (HFRN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hartford Retirement Network Corp. is a senior retirement solutions company. It concentrates on senior housing and retirement services and products mainly in China. It is a foremost retirement service provider and retirement facility management company in China. Established in 2004, Hartford Retirement Network has its corporate office in Rosemead, California.

The Company previously went by the name Dynamic Gold Corp. It changed its name to Hartford Retirement Network Corp. in June of last year. As of May 4, 2017, Hartford Retirement Network Corp. operates as a subsidiary of Hartford International Retirement Network, Inc. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Hartford Retirement Network has an integrated network platform with proprietary technologies. This is to serve its clients in China and the United States.

Last month, Hartford Retirement Network (HFRN) announced it entered into a Securities Purchase Agreement with HQDA International Holdings Limited, a Hong Kong company (HQDA), for the sale of 47,500,000 shares of its common stock for a total of US$7,124,109. HQDA will be a majority shareholder of Hartford Retirement Network after the closing.

HQDA centers on the senior-care industry investment and operation management. It provides premier service within the Chinese senior-care industry. The company formed in 2012.

Mrs. Ziyun Xu, Chairperson of HQDA, highly valued the acquisition of HFRN. Mrs. Xu stated that "I am really looking forward to helping to build the future of HFRN, and truly believe that this transaction will facilitate the development of both HFRN and HQDA, and we will take great effort to expand our business in the international space."

Hartford Retirement Network also has its Hartford Hotel in Rosemead, California. The hotel size is three floors and it has 63 rooms. Its on-site service facilities include dining options (complimentary full breakfast daily); and a Business Center – One Meeting Room.

Services include 24-hour reception; Concierge Service; tour/ticket assistance; dry cleaning/laundry services; free lobby newspapers, as well as luggage storage.

Hartford Retirement Network Corp. (HFRN), closed Monday's trading session at $2.50, up 8.70%, on 200 volume with 1 trade. The average volume for the last 60 days is 106 and the stock's 52-week low/high is $0.585/$3.00.


Maricann Group, Inc. (MRRCF)

OTC Markets, Barchart, Weed Newswire, Stockhouse, Investopedia, Insider Financial, YCharts, The Street, MarketWatch, 4-Traders, NewCannabisVentures, Marketwired, Investors Hub, and TradingView reported on Maricann Group, Inc. (MRRCF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Established in 2013, Maricann Group, Inc. produces and distributes marijuana for medical purposes. It offers dried marijuana, cannabis oil, and gums. Additionally, the Company provides accessories. This includes vaporizers, grinders, and other paraphernalia. Maricann Group has its headquarters in Burlington, Ontario, and Munich, Germany. The Company has production facilities in Langton, Ontario. Maricann Group lists on the OTC Markets’ OTCQB.

Maricann Group is a licensed producer of medical cannabis under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Maricann Group has federal licenses in Canada to cultivate, extract, formulate, as well as distribute cannabis.

In Langton, Ontario, Maricann operates a medicinal cannabis cultivation, extraction, and formulation and distribution business under federal license from the Government of Canada, and Dresden, Saxony, Germany.

The Company’s new, state-of-the-art, fully dedicated cannabis production facility in Langton is on 100 acres of land. At present, Maricann is undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, to support existing and future patient growth.

Maricann Group’s Germany-based Ebersbach facility targets the substantial European market with 820,000 sq. ft. of cultivation space and greater than 12,000 patients. Maricann has developed educational programming for patients and healthcare professionals. Through exclusive pharmacy agreements with roughly20 percent of the nation’s pharmacies, Maricann is working to become a leading provider of cannabis at physical point-of-sale locations that patients trust.

In August of 2017, Maricann Group acquired NanoLeaf Technologies. NanoLeaf is a biotechnology company. It has licensing rights to a number of globally patented technologies that provide proven pharmaceutical, nutraceutical, cosmetic, and functional beverage drug delivery formulations. Maricann’s Vesisorb is the first standardized dose cannabinoid soft gel capsule with a nano-dispersed carrier for the drug that is ideal for ingestional bioavailability.

Recently, Maricann Group announced that it received all of the required approvals from Health Canada to begin cultivation in Phase One of the Company’s new, state-of-the-art grow facility in Langton, Ontario. This is Maricann Group’s third license issued by Health Canada.

Furthermore, in April, Maricann Group announced that it is now part of an exclusive group of Canadian Licensed Producers to be Good Manufacturing Practice (GMP) certified in accordance with the European Medicines Agency’s GMP standards.

Last week, Maricann Group announced that it completed the acquisition of all outstanding shares of Haxxon AG. This acquisition of Haxxon forms an essential aspect of Maricann’s European expansion strategy.

Maricann is now positioned to enter the Swiss market via Haxxon’s production of feminized high CBD cannabis plants.  Haxxon operates within a 6,000 sq. m. (approximately 64,500 sq. ft.) indoor facility in Regensdorf, Switzerland.

Maricann Group, Inc. (MRRCF), closed Monday's trading session at $1.54, up 1.99%, on 119,195 volume with 132 trades. The average volume for the last 60 days is 81,906 and the stock's 52-week low/high is $0.8698/$3.60.


Right On Brands, Inc. (RTON)

PennyStockVault, SmallCapVoice, InvestorsHub, MarketWatch, OTC Markets, Barchart, Stockhouse, Capital Cube, Investors Hangout, YCharts, and Investors News Magazine reported on Right On Brands, Inc. (RTON), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Right On Brands, Inc. is a consumer goods company listed on the OTC Markets Group’s OTCQB. The Company specializes in the brand development of health conscious, hemp-infused food and beverage products. Right On Brands comprises three subsidiaries. These are Humbly Hemp, Endo Brands, and Humble Water Company. Right On Brands is headquartered in Los Angeles, California.

The Company is developing, marketing, and investing in industrial hemp, cannabis, adaptogenic superfoods and natural water for a new generation of health-conscious consumers. These products are becoming a part of the daily lives of millions.

Humbly Hemp is a product line of hemp-based products. Each Humbly Hemp bar is kosher, vegan, soy free, dairy free, and gluten-free. They are also free of all top 11 allergens. The basis of the Company’s protein bars are with gluten free rolled oats, hemp seeds, and plant protein.

Endo Water is pH balanced and micro-clustered for antioxidant protection. Additionally, it is oxygenated for improved performance and energy. Endo Water is available in Berry Acai, Lemon Lime, Cucumber, and Watermelon flavors.

Endo Water is infused with a 99.5 percent pure CBD oil, processed employing Nano Technology. This makes the particles one-millionth of its normal size. This process allows the Nano-Sized CBD's to immediately penetrate one’s cells versus the lengthy process of being absorbed by the body's digestive system.

Right On Brands’ Humble Water Company product is a natural spring water sourced from an ancient ice age aquifer at the foothills of the Rocky Mountains situated at the only triple watershed in North America. Humble Water is high in natural alkalinity and it is pure.

This past December, Right On Brands announced that Medical Biochemist Dr. Ashok Patel was appointed Director of Product Development. His expertise is in natural oils and extracts.

This will permit Right On Brands to develop first of its kind, healthy hemp products to be marketed under the Humbly Hemp and Endo Brands. Dr. Patel uses his expertise in medical biochemistry to formulate products, which are safe and effective and provide the benefits of the latest innovations in science.

Also in December, Right On Brands announced the introduction of the above-mentioned Endo Water. This is the first offering of a premium CBD product line to be marketed by the Company.

All of the future CBD offerings will be a part of the Endo Brands family of products. Endo Brands is the wholly-owned subsidiary of Right On Brands. The initial shipment of product was received by Right On Brands. Moreover, an aggressive launch in Southern California is planned for early 2018.


Right On Brands, Inc. (RTON), closed Monday's trading session at $0.20, up 0.05%, on 6,000 volume with 1 trade. The average volume for the last 60 days is 16,823 and the stock's 52-week low/high is $0.1681/$0.731.


Eguana Technologies, Inc. (EGTYF)

Streetwise Reports, Investors Hub, and Stockhouse reported on Eguana Technologies, Inc. (EGTYF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Eguana Technologies, Inc. is one of the leaders in power conversion and control systems for distributed energy storage. The Company designs and manufactures high performance power controls for commercial and residential energy storage systems. It is the foremost supplier of power controls for solar self-consumption, grid services, as well as demand charge applications at the grid edge. Listed on the OTCQB, Eguana Technologies is based in Calgary, Alberta.

Eguana Technologies is one of the leaders in power conversion and control systems for distributed energy storage. It delivers proven, durable, high quality solutions from its high capacity manufacturing facilities in Europe and North America. Additionally, the Company delivers grid edge power electronics for fuel cell, photovoltaic, and battery applications.

Eguana Technologies has thousands of its proprietary energy storage inverters installed in the European and North American markets. Its corporate vision is to become the top international supplier of intelligent power electronics for grid tied residential storage applications.

The Company has its AC Battery™. The Eguana AC Battery is a total grid ready power control solution. It accepts dispatch commands from any control network utilizing open communication protocols. The AC Battery is constructed around Eguana’s patented Bi-Direx power controls.

The AC Battery is 'control' ready. It can be commanded via a Sunspec-compliant ModBus interface using any third-party energy management system. The AC Battery is a suitable fit for small commercial and light industrial applications. It is compatible with all advanced battery technologies.

Eguana’s Patented "pulsed step wave" technology takes a different approach to reducing conducted losses through sharing the current across parallel bridges and recombining into the AC output waveform by way of a unique transformer topology and advanced control software. The single power conversion step further lessens losses. Also, it allows quicker and more stable control loops than conventional inverters.

Last month, Eguana Technologies announced that Sossin Group LLC (New York based) teamed up with Swezey Fuel and National Energy Connection (NEC) to offer a complete solar + storage package for Long Island residents. In addition to electricity cost savings, Swezey customers will have complete back up power mode provided by the Eguana AC battery. The Eguana AC Battery can be purchased separately for back up power installations or as part of the total package.

Today, Eguana Technologies announced the completion of a multi-year master supply agreement with its German automotive partner. The multi-year contract has an initial year forecasted value of $13 million.

The delivery expectations are to be completed within this calendar year. The initial product release of $3.2 million has been received. Planned shipments will commence this coming May followed by three more product releases.

Eguana Technologies, Inc. (EGTYF), closed Monday's trading session at $0.16, up 1.59%, on 30,675 volume with 13 trades. The average volume for the last 60 days is 42,809 and the stock's 52-week low/high is $0.12/$0.2822.


Rebel Group, Inc. (REBL)

Awesome Penny Stocks, OTC Markets, InvestorsHub,, 4-Traders, The Street, Stockhouse, GuruFocus, Simply Wall St, Barchart, WalletInvestor, and Penny Stock Hub reported on Rebel Group, Inc. (REBL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rebel Group, Inc., by way of its subsidiaries, organizes, promotes, and hosts mixed martial arts (MMA) events in China and Singapore. An MMA entertainment company, Rebel’s emphasis is on organizing, promoting and hosting MMA events that attract talented fighters from around the world. Rebel Group lists on the OTC Markets Group’s OTCQB. The Company is headquartered in Singapore. Rebel Group is a subsidiary of Total Glory International Limited.

Rebel Group operates under the Rebel Fighting Championship brand. Rebel Group carries out its operations through managing events, fighters, ticket sales, sponsorships, and also pay-per-view purchases.

The Company produces and distributes its events via the internet and social media. It works to sell the rights to distribute videos of its MMA events to television stations.

Today, Rebel Group announced the viewership results of its MMA event held in Shanghai, China on April 29, 2018. REBEL FC 7 – FIGHT FOR HONOUR took place at the Kerry Hotel in Shanghai China.

Approximately 1,500 viewed the event live. Furthermore, through Rebel Group’s five major MMA & Sports professional media partners and nine broadcasting media partners, viewership of the tournament broke the Company’s previous historical records.

Television viewership reached 4,500,000 viewers. This included 1,290,000 from Guangdong Sports Channel, Rebel Group's official broadcast partner in China for all of this year’s events.

The total digital broadcast viewership reached 8,332,000. This included 2,572,000 viewers on Yizhibo, 1,423,000 on QiE, and 1,423,000 on PPTV Sports. On social media, viewership totaled 85,362,000. Highlights included 77,800,000 hashtag views on Weibo and 7,000,000 Miaopai Video views.

Mr. Justin Leong, Rebel Group Chief Executive Officer, stated, "Our 7th MMA event broke all previous records, both quantitatively and qualitatively, as we witnessed a uniquely thrilling event. This success was due in no small part to the strong relationships we have developed with our media partners...We believe that Rebel Group will continue to deliver top notch fights and grow our fandom. We are excited to position ourselves to hold more events per year and continue to provide exceptional entertainment in China and internationally."

Rebel Group, Inc. (REBL), closed Monday's trading session at $2.00, even for the day, on 300 volume with 3 trades. The average volume for the last 60 days is 87 and the stock's 52-week low/high is $1.70/$5.00.


The QualityStocks Company Corner

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the arrival of the second shipment of dried cannabis materials at the Pharmacy Australia Centre of Excellence ("PACE") at the University of Queensland ("UQ"). The shipment came from PreveCeutical's partner, a Canadian licensed producer.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.26, up 32.28%, on 18,282 volume with 13 trades. The average volume for the last 60 days is 21,429 and the stock's 52-week low/high is $0.01/$0.80.

Recent News


Aftermaster, Inc. (OTCQB: AFTM)

The QualityStocks Daily Newsletter would like to spotlight Aftermaster, Inc. (AFTM).

Aftermaster, Inc. (OTCQB: AFTM), an award-winning, leading edge audio technology company dedicated to “Mastering the Art of Sound,” offers unparalleled technological audio innovations for the professional and consumer audio markets. The company’s subsidiary, Aftermaster Audio Labs, is an industry leading mastering and recording company with studios located in the heart of Hollywood, California. Aftermaster challenged the status quo for digital audio by creating a sophisticated process that enhances the listening experience in applications that span far beyond music (

Aftermaster, Inc. (OTCQB: AFTM), with offices in Scottsdale, Arizona, and Hollywood California, is an award-winning, leading-edge audio technology company that specializes in the development of proprietary and groundbreaking audio technologies and products. The company also operates world-class mastering and recording studios located in the heart of Hollywood, California, in the famous Crossroads of the World complex along Sunset Boulevard.

Aftermaster and its subsidiaries are engaged in the development and commercialization of proprietary (patents issued and pending), leading-edge audio and video technologies for professional and consumer use including the award-winning AfterMaster® audio technology, ProMaster™ and Aftermaster Pro™. Aftermaster is unique in the audio world because its team has produced, engineered and mastered more hit records than any audio company in the world. The Aftermaster team knows what sounds right and the Company holds a unique position in the world of audio technology.

The Company’s underlying technology, Aftermaster audio, delivers an audio experience unrivaled by any audio company. It brings an unprecedented new quality level to consumer audio by offering unparalleled clarity, depth, fullness and a significant volume increase to audio recordings without distortion or altering the original recording. Its versatility and smart processing characteristics make it effective across a broad range of applications from consumer electronics to industrial applications.

The Company also operates Aftermaster Recording and Mastering Studios which include the renovated production facilities of legendary director Alfred Hitchcock and the iconic recording studios of Crosby, Stills and Nash.

Aftermaster Labs maintains five primary business units: Aftermaster proprietary semiconductor chip and software for OEM licensing, proprietary consumer electronics, professional music mastering, online mastering, recording and mixing at its Aftermaster Recording and Master Studios, and Audio Consulting services. The Aftermaster semiconductor chip and software is used for embedding in consumer products, Aftermaster-developed and branded consumer and professional electronic products, ProMaster on-line music mastering for independent music artists and in-studio professional music mastering services.

Aftermaster has increasingly attracted interest from some of the music industry’s leading audio companies. A newly expanded partnership with TuneCore, the leading digital music distribution and publishing administration provider, gives TuneCore members access to Promaster through its instant mastering service which offers audio mastering of unparalleled quality at the click of a button. The Company also recently entered into a licensing agreement with Muzik headphones for use of its Aftermaster chip in their new headphone line.

The company’s first groundbreaking consumer product – the Aftermaster Pro – is designed to solve the universally widespread problem of poor, variable audio levels of television audio. Aftermaster Pro, which is smaller than an iPhone, masters and remasters inconsistent TV audio in real-time, creating an audio experience that offers clear, full-bodied depths of sound and most importantly, overall balanced audio. The Aftermaster Pro virtually eliminates the need to adjust TV volume to hear dialogue or to reduce the level of loud special effects. The Aftermaster Pro sells for $179 and is enjoying strong growth in sales to over 65 countries.

With the Company’s Promaster, state-of-the-art proprietary algorithms, artists receive four CD quality mastered versions of their track including “Powerful,” “Radio Ready,” “Bass Enhanced,” and “Vocal Enhanced.”  TuneCore artists have access to exclusive pricing on the Promaster pay-as-you-go instant mastering, as well as unlimited monthly and annual subscriptions. Aftermaster also holds a license agreement with headphone manufacturer, Muzik, Inc., for the use of Aftermaster’s patented audio remastering and audio enhancement technology.

Aftermaster won three Envisioneering Innovation and Design Awards at the 2016 Consumer Electronics Show in Las Vegas for both its Aftermaster TV device and its BelaSigna 300 processor semiconductor chip created through a partnership with ON Semiconductor. Aftermaster was also named an honoree for its ProMaster audio technology.

Aftermaster Audio Labs is led by a group of world-class audio engineers and music industry veterans who have been involved with the development and implementation of countless successful proprietary audio technologies and products.

The Team

Aftermaster co-founder and CEO Larry Ryckman is an award-winning entertainment and technology executive with over 25 years of achievements in the music and entertainment industries.

Shelly Yakus, co-founder and chief engineer at Aftermaster Audio Labs, is a renowned music producer, audio engineer/mixer and is widely considered the best engineer and mixer in the music industry.

Justin Timberlake, a Grammy and Emmy award-winning singer/songwriter/producer and actor, is a co-owner of Aftermaster Audio Labs, Inc. Timberlake is widely considered to be one of pop culture’s most influential entertainers in the world.

Peter Doell is one of the best-known mastering engineers in the world with over 35 years of experience mastering and engineering hundreds of chart-topping records, film scores and TV spots. Rodney Jerkins is an 8-time Grammy Award winning music producer/songwriter and considered to be one of the most influential and successful producers in the music industry.

Paul Wolff is a senior engineer and product development consultant at Aftermaster Audio Labs. Wolff has been involved in the professional music and audio industries as an audio engineer and product designer and manufacturer of professional audio products for more than 35 years.

Thousands of hours of testing millions of songs and audio sources of all types have been processed using Aftermaster’s award-winning technology and the results speak for themselves with platinum records, numerous strategic partnerships, and overwhelming industry support.

Aftermaster, Inc. (AFTM), closed the day's trading session at $0.07822, up 10.17%, on 6,473 volume with 3 trades. The average volume for the last 60 days is 403,124 and the stock's 52-week low/high is $0.035/$0.31.

Recent News


Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) renewal of its DehydraTECH™ license with Nuka Enterprises LLC could help make it a compelling investment opportunity in the cannabis industry as its licensing and royalties from that technology platform deliver recurring revenue that could unlock significant value for its shareholders, according to an article by CFN Media Group (

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.51, up 6.34%, on 284,527 volume with 438 trades. The average volume for the last 60 days is 183,474 and the stock's 52-week low/high is $0.27/$2.54.

Recent News


First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt Corp. (TSX-V: FCC, ASX: FCC, OTCQX: FTSSF) (the "Company") today announces President and CEO Trent Mell will be giving a keynote presentation on the cobalt market supply and demand fundamentals at a Benchmark Mineral Intelligence event in Vancouver on Wednesday, May 16, 2018 at 11:30 a.m.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.58, off by 2.77%, on 72,154 volume with 50 trades. The average volume for the last 60 days is 139,259 and the stock's 52-week low/high is $0.3148/$1.3041.

Recent News


Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands Inc. (OTC: ZNGY), the nation’s leading next-generation energy and technology company, recently announced the election of Joshua Campbell to its board of directors and the addition of Chris Crabtree to the executive leadership team. The company aims to increase the enterprise value and bottom line of life-long clients while significantly reducing the carbon footprint in the United States, as well as the demand on the national energy grid and water supply.

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0059, even for the day, on 284,500 volume with 12 trades. The average volume for the last 60 days is 3,313,870 and the stock's 52-week low/high is $0.0027/$0.045.

Recent News


Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (VRCP).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Companies Race to Spread the Benefits of Cryptocurrency," featuring Virtual Crypto Technologies Inc. (OTCQB: VRCP). To hear the NetworkNewsAudio version, visit: To read the original editorial, visit:

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website,, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.163, off by 14.21%, on 16,676 volume with 14 trades. The average volume for the last 60 days is 35,428 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, today announces the launch of its cryptocurrency and blockchain talk show entitled "Bitcoin Talk Show" airing on Phoenix North America Chinese Channel ("Phoenix North America"). This innovative television program will begin airing the first week of June 2018. Local Chinese investors and business owners will be invited to the Phoenix North America headquarters to attend the live taping where they will discuss cryptocurrency and blockchain technology with the Company's Analysts.

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.51, off by 0.97%, on 39,458 volume with 21 trades. The average volume for the last 60 days is 54,896 and the stock's 52-week low/high is $0.40/$1.58.

Recent News


Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Statistics portal Statista forecasts the global digital payments market to grow at a CAGR of 13.5 percent from $3.26 trillion in 2018 to more than $5.41 trillion in 2022 ( This includes online processed payment transactions, mobile point-of-sale payments and digital consumer commercial transactions. The digital commerce segment is the largest of the three, with a total transaction value of more than $2.87 trillion in 2018. Net Element, Inc. (NASDAQ: NETE), a company focused on providing solutions and services for mobile payments and value-added digital transactions, is well positioned to capitalize on this projected growth.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $7.85, off by 2.48%, on 197,338 volume with 851 trades. The average volume for the last 60 days is 932,538 and the stock's 52-week low/high is $2.556/$33.51.

Recent News


Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

The CBD segment is one of the main drivers of the huge growth in the cannabis industry, with the Hemp Business Journal projecting this segment to grow to $2.1 billion by 2020 ( In addition, market research analysts Technavio forecast that the global hemp-based foods market will grow at a CAGR of over 24 percent through 2021 ( Earth Science Tech, Inc. (OTC: ETST) is an innovative biotech company with a primary focus on delivering high grade hemp-derived, cannabidiol (CBD)-based products to this market. It has a further focus on the development of diagnostic tools, testing processes and medical devices. Also today, NetworkNewsWire released a report on the company detailing how ETST is well on its way to becoming a licensed distributor and bringing its products to the Canadian marketplace. To view the full article, visit:

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.83, off by 1.19%, on 19,328 volume with 17 trades. The average volume for the last 60 days is 17,146 and the stock's 52-week low/high is $0.324/$1.62.

Recent News


ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF).

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” ABcann Global CEO Barry Fishman said.

ABcann Global owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

ABcann has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by ABcann’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting ABcann’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

ABcann’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with ABcann’s philosophy of quality and innovation.

ABcann’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, ABcann also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

ABcann Global (ABCCF), closed the day's trading session at $1.25, up 2.46%, on 279,109 volume with 227 trades. The average volume for the last 60 days is 307,555 and the stock's 52-week low/high is $0.642/$3.2929.

Recent News


Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.041, up 4.59%, on 142,543 volume with 30 trades. The average volume for the last 60 days is 330,735 and the stock's 52-week low/high is $0.0161/$0.115.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.